Short Interest in Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY) Drops By 38.7%

Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totaling 63,804 shares, a drop of 38.7% from the June 30th total of 104,061 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 131,085 shares, the short-interest ratio is presently 0.5 days.

Wall Street Analysts Forecast Growth

Separately, Zacks Research downgraded Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 22nd. Two equities research analysts have rated the stock with a Sell rating, According to data from MarketBeat, Sonic Healthcare presently has a consensus rating of “Sell”.

Get Sonic Healthcare alerts:

Get Our Latest Analysis on Sonic Healthcare

Sonic Healthcare Trading Up 1.3%

Sonic Healthcare stock traded up $0.20 during trading hours on Thursday, reaching $15.79. 31,200 shares of the company’s stock traded hands, compared to its average volume of 108,958. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.90 and a current ratio of 1.01. Sonic Healthcare has a fifty-two week low of $12.94 and a fifty-two week high of $19.25. The firm’s 50 day moving average is $14.26 and its 200-day moving average is $14.73.

About Sonic Healthcare

(Get Free Report)

Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.

The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.

See Also

• Five stocks we like better than Sonic Healthcare
• Microsoft Just Flipped the AI Spending Narrative Overnight
• Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
• Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
• Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes

Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.